Tag: are-displayed
-
Allergan profit beats estimates, share buybacks planned
The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…
-
Allergan profit beats estimates, share buybacks planned
The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…
-
Vaccines put brakes on yellow fever outbreaks, more may pop up: WHO
By Tom Miles GENEVA (Reuters) – A major yellow fever outbreak in Angola and two smaller flare-ups in Uganda and Congo are largely under control but countries have been warned to be vigilant in case the disease pops up elsewhere, the World Health Organization (WHO) said on Tuesday. Yellow fever is hard to spot early…
-
U.S. clears genetically modified salmon for human consumption
By Julie Steenhuysen and Tom Polansek CHICAGO (Reuters) – U.S. health regulators on Thursday cleared the way for a type of genetically engineered Atlantic salmon to be farmed for human consumption – the first such approval for an animal whose DNA has been scientifically modified. Five years ago, the U.S. Food and Drug Administration first…